ThesisInterleukin 10 and 12 polymorphisms and their association with treatment outcome of patients with chronic hepatitis C infection
ThesisInterleukin 10 and 12 polymorphisms and their association with treatment outcome of patients with chronic hepatitis C infection
ThesisSingle nucleotide polymorphism of IL-10 and IL- 28b as predictors to the response of interferon therapy in HCV infected children
ThesisSingle nucleotide polymorphism of IL-10 and IL- 28b as predictors to the response of interferon therapy in HCV infected children
ThesisThe clinical significance of IL-10 and IL-12B gene Polymorphisms as predictor of response to HCV patients treated by peginterferon plus ribavirin
ThesisThe clinical significance of IL-10 and IL-12B gene Polymorphisms as predictor of response to HCV patients treated by peginterferon plus ribavirin
ThesisRelation between interleukin-10 polymorphism and the efficacy of interferone–based therapies in HCV patients
ThesisRelation between interleukin-10 polymorphism and the efficacy of interferone–based therapies in HCV patients
ThesisIL28B gene polymorphism and spontaneous hepatitis C virus clearance in sickle cell disease patients
ThesisIL28B gene polymorphism and spontaneous hepatitis C virus clearance in sickle cell disease patients
ThesisExpression of IL-4 (VNTR intron3) and IL-10 (-627) genes polymorphism in childhood immune thrombocytopenic purpura
ThesisExpression of IL-4 (VNTR intron3) and IL-10 (-627) genes polymorphism in childhood immune thrombocytopenic purpura
ThesisAssociation of cytokine gene polymorphism and response to corticosteroid therapy in children with nephrotic syndrome
ThesisAssociation of cytokine gene polymorphism and response to corticosteroid therapy in children with nephrotic syndrome
ThesisAssociation of transforming growth factor β1 gene polymorphism with natural clearance of hepatitis C virus
ThesisAssociation of transforming growth factor β1 gene polymorphism with natural clearance of hepatitis C virus
ThesisOsteopontin gene polymorphism as marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C
ThesisOsteopontin gene polymorphism as marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C